BRAIN GAMMA-AMINOBUTYRATE AMINOTRANSFERASE (GABA-T) AND MONOAMINE-OXIDASE (MAO) IN PATIENTS WITH ALZHEIMERS-DISEASE

被引:54
作者
SHERIF, F
GOTTFRIES, CG
ALAFUZOFF, I
ORELAND, L
机构
[1] UNIV UPPSALA, CTR BIOMED, DEPT MED PHARMACOL, BOX 593, S-75124 UPPSALA, SWEDEN
[2] HUDDINGE HOSP, DEPT PATHOL, STOCKHOLM, SWEDEN
[3] GOTHENBURG UNIV, DEPT PSYCHIAT & NEUROCHEM, S-41124 GOTHENBURG, SWEDEN
关键词
AMINOBUTYRATE AMINOTRANSFERASE; ALZHEIMERS DISEASE; MONOAMINE OXIDASE; HUMAN BRAIN; POSTMORTEM BRAIN;
D O I
10.1007/BF02260906
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Activities of Gamma-aminobutyrate aminotransferase (GABA-T) and Monoamine oxidase (MAO)-A and -B were estimated in postmortem brains from 6 control subjects without psychiatric or neurologic disorders and 8 histopathologically verified cases of patients with Alzheimer's disease and senile dementia of Alzheimer type (AD/SDAT). The enzyme activities were examined in four cortical brain regions, three nuclei in the basal ganglia, thalamus and white matter. GABA-T activities in the cortical regions (frontal, parietal, occipital and temporal cortices) and nucleus caudatus were significantly lowered in the AD/SDAT patients. The MAO-A activities were significantly increased in the occipital cortex, caudate nucleus, thalamus and white matter in the AD/SDAT patients. No significant differences were found in the other regions (frontal cortex, parietal cortex, temporal cortex, putamen and globus pallidus). The MAO-B activities in three cortical regions (frontal, parietal and occipital cortices), thalamus and white matter were significantly increased in the AD/SDAT patients, whereas no difference was apparent in the other regions. The changed activities could not be correlated with age or postmortem time. The present results are the first describing decreased GABA-T activities as well as increased MAO-A activities in brain from patients with AD/SDAT, while the results with MAO-B support previous findings. A possible connection was found between the order of magnitude of the changes in enzyme activities and the severity of the disease.
引用
收藏
页码:227 / 240
页数:14
相关论文
共 66 条
[1]   PREVALENCE OF DEMENTIA DISORDERS IN INSTITUTIONALIZED SWEDISH OLD-PEOPLE - THE WORK LOAD IMPOSED BY CARING FOR THESE PATIENTS [J].
ADOLFSSON, R ;
GOTTFRIES, CG ;
NYSTROM, L ;
WINBLAD, B .
ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 (03) :225-244
[2]   INCREASED ACTIVITY OF BRAIN AND PLATELET MONOAMINE-OXIDASE IN DEMENTIA OF ALZHEIMER TYPE [J].
ADOLFSSON, R ;
GOTTFRIES, CG ;
ORELAND, L ;
WIBERG, A ;
WINBLAD, B .
LIFE SCIENCES, 1980, 27 (12) :1029-1034
[3]  
AOYAGI T, 1990, CHEM PHARM BULL, V38, P1748
[4]  
ARAI H, 1985, Neuroscience Research, V2, P486, DOI 10.1016/0168-0102(85)90020-3
[5]  
ARAI Y, 1985, BIOGENIC AMINES, V2, P65
[6]   DECREASED CSF CONCENTRATIONS OF HOMOVANILLIC-ACID AND GAMMA-AMINOBUTYRIC ACID IN ALZHEIMERS-DISEASE - AGE-RELATED OR DISEASE-RELATED MODIFICATIONS [J].
BAREGGI, SR ;
FRANCESCHI, M ;
BONINI, L ;
ZECCA, L ;
SMIRNE, S .
ARCHIVES OF NEUROLOGY, 1982, 39 (11) :709-712
[7]   GALANIN IMMUNOREACTIVITY IS INCREASED IN THE NUCLEUS BASALIS OF MEYNERT IN ALZHEIMERS-DISEASE [J].
BEAL, MF ;
MACGARVEY, U ;
SWARTZ, KJ .
ANNALS OF NEUROLOGY, 1990, 28 (02) :157-161
[8]   NEUROCHEMICAL CHARACTERISTICS OF ALUMINUM-INDUCED NEUROFIBRILLARY DEGENERATION IN RABBITS [J].
BEAL, MF ;
MAZUREK, MF ;
ELLISON, DW ;
KOWALL, NW ;
SOLOMON, PR ;
PENDLEBURY, WW .
NEUROSCIENCE, 1989, 29 (02) :339-346
[9]  
BLENNOW K, 1990, HETEROGENEITY ALZHEI
[10]   CHEMICAL PATHOLOGY OF ORGANIC DEMENTIAS .1. VALIDITY OF BIOCHEMICAL MEASUREMENTS ON HUMAN POSTMORTEM BRAIN SPECIMENS [J].
BOWEN, DM ;
SMITH, CB ;
WHITE, P ;
GOODHARDT, MJ ;
SPILLANE, JA ;
FLACK, RHA ;
DAVISON, AN .
BRAIN, 1977, 100 (SEP) :397-426